By
MikeH on
December 3, 2012
Just because the American Diabetes Association has the word American in its name, doesn’t mean the organization’s reach doesn’t extend outside the U.S.
The ADA is going more global than ever now by holding its first-ever Middle East Congress in Dubai. The inaugural summit being held tomorrow (Tuesday) through Thursday this week is expected to bring in 1,400 to 2,000 people for what ADA organizers are calling a “mini Scientific Sessions” (the ADA’s huge annual…
Read more »
Losing the ability to sense low blood sugars is one of the scariest things for those of us living with diabetes.
For one college student at Purdue University, that hypoglycemia unawareness led to an average of three ER visits a week (!) Even with a CGM, this young man diagnosed with type 1 at age 5 wasn’t able to avoid the insulin reactions because they came on too quickly. It got to the point where…
Read more »
Sometimes, diabetes science confuses me.
Let’s take the news of an emerging class of diabetes drugs (type 2-focused) that apparently do something we’ve always thought was bad… but it’s actually not.
Sodium-glucose transporter (SGLT-2) inhibitors increase insulin production and effectiveness and stop the liver from producing too much glucose. Basically, they work by spilling glucose over into the urine which leads to less sugar in your bloodstream. The effect: lower BGs and A1Cs.
Sure, it…
Read more »
By
MikeH on
June 21, 2012
One of the 64-million-dollar questions in the diabetes world is why more of us don’t do a better job tracking our blood sugars.
I know that’s been a key question in my 28 years of living with type 1.
Fitting with the behavioral change theme of this year’s ADA Scientific Sessions, and how doctors can motivate us to “do better,” a breakfast session explored the issue of BG logging and why it’s such a challenge…
Read more »
